Eflornithine and/or Sulindac in Preventing Recurrence of High-Risk Adenomas and Second Primary Disease in Patients with Stage 0-III Colon or Rectal Cancer

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeTrial IDs
Phase IIIPreventionActive18 and overS0820
NCI-2012-02067, SWOG-S0820, NCT01349881

Trial Description

Summary

This randomized phase III trial studies how well eflornithine works compared to sulindac in preventing the return of the disease (recurrence) of high-risk adenomas and second primary disease in patients with stage 0-III colon or rectal cancer. Drugs used in chemotherapy, such as eflornithine and sulindac, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Further Study Information

PRIMARY OBJECTIVES:

I. To assess whether the combination of eflornithine and sulindac is effective in reducing the three-year event rate (high-risk adenomas and second primary colorectal cancers) in patients with previously treated stage 0-III colon or rectal cancer.

SECONDARY OBJECTIVES:

I. To assess whether the combination of eflornithine and sulindac (compared to corresponding placebos) has efficacy against colorectal lesions with respect to high-grade dysplasia, adenomas with villous features, adenomas 1 cm or greater, multiple adenomas, any adenomas >= 0.3 cm, total advanced colorectal events, or total colorectal events.

II. To assess quantitative and qualitative toxicities of patients when treated with the combination of eflornithine and sulindac compared to corresponding placebos.

III. To evaluate a minimal set of tagging single nucleotide polymorphisms across multiple genes relevant to eflornithine and sulindac, in order to characterize associations with decreased adenoma/second primary colorectal cancer (CRC) risk and adverse events.

IV. To evaluate biomarker responses of treatment effect using novel microfluidics-based digital droplet detection system.

V. To explore the interaction of intervention arm and baseline statin use with respect to the 3-year event rate.

VI. To explore the interaction of the intervention arm and patient-reported meat consumption with respect to the 3-year event rate.

VII. To perform population pharmacokinetic (PK) analysis of eflornithine and sulindac in patients with previously treated stage 0-III colon or rectal cancer.

OUTLINE: Patients are randomized to 1 of 4 treatment arms.

ARM I: Patients receive eflornithine placebo orally (PO) once daily (QD) and sulindac placebo PO QD for 36 months in the absence of disease progression or unacceptable toxicity.

ARM II: Patients receive eflornithine PO QD and sulindac placebo PO QD for 36 months in the absence of disease progression or unacceptable toxicity. (CLOSED TO ACCRUAL PER PROTOCOL DATED 01/27/17)

ARM III: Patients receive eflornithine placebo PO QD and sulindac PO QD for 36 months in the absence of disease progression or unacceptable toxicity. (CLOSED TO ACCRUAL PER PROTOCOL DATED 01/27/17)

ARM IV: Patients receive eflornithine PO QD and sulindac PO QD for 36 months in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up annually for 5 years.

Eligibility Criteria

Inclusion Criteria:

STEP 0: REGISTRATION (Optional)

Patients with a primary colon or rectal cancer resection who are potentially eligible for S0820 may be pre-registered at Step 0; patients registered to Step 0 will appear on an institutional patient tracking report; patients registered to Step 0 are not registered to the S0820 protocol; to participate in S0820, patients must be registered to Step 1 after patient is consented and evaluation of eligibility; patients registered to S0820 at Step 0 continuing to Step 1 registration must use the same Southwest Oncology Group (SWOG) patient identification (ID) for registration to S0820 Step 1

STEP 1: REGISTRATION

Patients must have a history of stage 0, I, II or III colon or rectal adenocarcinoma that has been treated per standard care with resection alone or in combination with radiation or chemotherapy; adjuvant chemotherapy and radiation therapy (RT) treatment must have been completed at least 30 days prior to registration

Patients with history of segmental resections are eligible (i.e. right colectomy, extended right colectomy, transverse colectomy, left colectomy, extended left colectomy, sigmoid colectomy, low anterior resection, abdominoperineal resection); the definition of resection does not include endomucosal resection (EMR); patients that have received total proctocolectomy are ineligible

In addition to segmental resections, the following types of procedures are allowed: polypectomy: for Tis (stage 0) or pT1 patients only, resection may consist entirely of polypectomy (without completion of partial colectomy) if ALL of the following criteria are met:

  • Single specimen, completely removed
  • Clear margins
  • None of the following must be present:

*** Moderate or poor differentiation

*** Lymphovascular invasion

*** Perineural invasion

Transanal excision is allowed for pT1 rectal cancer patients with well or moderately differentiated tumors if National Comprehensive Cancer Network (NCCN) criteria for transanal excision are met, as stipulated here:

  • < 30% circumference of bowel
  • < 3 cm in size
  • Margin clear (> 3 mm)
  • Mobile, nonfixed
  • Within 8cm of anal verge
  • T1 only
  • Endoscopically removed polyp with cancer
  • No lymphovascular invasion or perineural invasion
  • Well to moderately differentiated
  • No evidence of lymphadenopathy on pretreatment imaging

***When the lesion can be adequately identified in the rectum, transanal endoscopic microsurgery (TEM) may be used; TEM for more proximal lesions may be technically feasible

Patients must be registered between 180 days and 465 days (inclusive) of primary resection; patients must show no evidence of disease (NED) based on post-operative colonoscopy (performed at least 180 days after the colon resection date or at least 120 days after the rectal resection date and prior to registration) and computed tomography (CT) scans* of chest, abdomen and pelvis (performed at least 180 days after the colon resection date or at least 120 days after the rectal resection date and prior to registration); patients with adenomas detected at the one-year postoperative colonoscopy are eligible if all adenomas have been completely removed

CT scan is for high risk patients, as per National Comprehensive Cancer Network (NCCN) guidelines and at the discretion of the treating physician

NOTE: magnetic resonance imaging (MRI) evaluation is an acceptable alternative to CT scans for eligibility purposes

Patients must not have cardiovascular risk factors including unstable angina, history of documented myocardial infarction or cerebrovascular accident, coronary artery bypass surgery, or New York Heart Association class III or IV heart failure; patients must not have known uncontrolled hyperlipidemia (defined as low-density lipoprotein cholesterol [LDL-C] >= 190 mg/dL or triglycerides >= 500 mg/dL) within the last 3 years prior to registration or uncontrolled high blood pressure (systolic blood pressure > 150 mm Hg) within 28 days prior to registration

Patients must not have a known history of familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer, or inflammatory bowel disease

Patients must have a pure tone audiometry evaluation to document air conduction within 30 days prior to registration; patients with hearing loss > 40 dB in any of the five tested frequencies (250 Hertz [Hz], 500 Hz, 1,000 Hz, 2,000 Hz, 4,000 Hz) are not eligible; patients with active ear infections should be tested only after the acute phase of infection has resolved; for optimal results, it is recommended that testing be conducted by an audiologist, in a hearing test room, with insert earphones; Note: sites should not order audiometry evaluation until the potential participant has met all other eligibility criteria required for this study

Patients must not have known hypersensitivity to eflornithine or sulindac or the excipients byproducts; patients must not have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other non-steroidal antiinflammatory drugs (NSAIDs)

Patients must not have documented history of gastric/duodenal ulcer within the last 12 months; participant must not currently be on treatment for gastric/duodenal ulcer or be experiencing symptoms at study entry; patients with gastroesophageal reflux disease (GERD) are eligible, however, and these patients may receive over-the-counter histamine-2 (H2) antagonists; proton-pump inhibitors, or other prescription-based treatment for GERD

Patients must have a Zubrod performance status of 0-1

Patients must not be expecting to receive radiation or additional chemotherapy

Patients must not be receiving or plan to receive concomitant corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), nor anticoagulants on a regular or predictable intermittent basis; (NSAID use may not exceed 10 days per month); patients may receive daily aspirin for cardiovascular prophylaxis as long as acetylsalicylic acid (ASA) is =< 100 mg per day or =< two 325 mg tablets per week

Patients must have the ability to swallow oral medication

Patients must have no significant medical or psychiatric condition that would preclude study completion; tests and exams for this determination should be completed within 28 days prior to registration

Total white blood cells (WBC) >= 4.0 x 10^3/mcL

Platelets >= 100,000/mcL

Hemoglobin > 11.0 g/dL

Serum bilirubin =< 2.0 mg/dL

Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) or alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2 x IULN (institutional upper limit of normal)

Serum creatinine =< 1.5 x IULN obtained within 28 days prior to registration

No other prior malignancy is allowed except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for > 5 years

Patients must not be pregnant or nursing; women/men of reproductive potential must have agreed to use an effective contraceptive method; a woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures

SPECIMEN SUBMISSION AND SUBSTUDY CRITERIA

Patients must be offered the option to participate in submission of specimens for banking for future translational medicine studies

Patients participating through PK sites, must be offered the option to submit blood specimens for population pharmacokinetic analysis

Patients must be offered the option to participate in the Diet and Lifestyle Substudy

REGULATORY CRITERIA

Individuals must not currently be participating in any other clinical trial for the treatment or prevention of cancer unless they are no longer receiving the intervention and are in the follow-up phase only; patients must also agree not to join such a trial while participating in this study

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

As part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system

Trial Contact Information

Trial Lead Organizations / Sponsors / Collaborators

SWOG

  • National Cancer Institute
Jason Adam Zell, Principal Investigator

Trial Sites

U.S.A.

Alaska
Anchorage

Alaska Breast Care and Surgery LLC

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Alaska Oncology and Hematology LLC

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Alaska Women's Cancer Care

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Anchorage Associates in Radiation Medicine

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Katmai Oncology Group

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Providence Alaska Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Fairbanks

Fairbanks Memorial Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Arizona
Gilbert

Banner MD Anderson Cancer Center

Tomislav Dragovich
Ph: 602-747-9738

Tomislav Dragovich
Principal Investigator

Arkansas
Hot Springs

Mercy Cancer Center-Hot Springs

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Jonesboro

Fowler Family Center for Cancer Care

Carroll Dean Scroggin
Ph: 870-936-7000

Carroll Dean Scroggin
Principal Investigator

California
Anaheim

Kaiser Permanente-Anaheim

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Antioch

Kaiser Permanente-Deer Valley Medical Center

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Auburn

Sutter Auburn Faith Hospital

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Auburn

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Baldwin Park

Kaiser Permanente-Baldwin Park

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Bellflower

Kaiser Permanente-Bellflower

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Berkeley

Alta Bates Summit Medical Center-Herrick Campus

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Burbank

Providence Saint Joseph Medical Center/Disney Family Cancer Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Burlingame

Mills-Peninsula Medical Center

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Cameron Park

Sutter Cancer Centers Radiation Oncology Services-Cameron Park

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Castro Valley

Eden Hospital Medical Center

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Costa Mesa

UC Irvine Health Cancer Center-Newport

Jason Adam Zell
Ph: 877-827-8839
Email: ucstudy@uci.edu

Jason Adam Zell
Principal Investigator

Davis

Sutter Davis Hospital

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Dublin

Epic Care-Dublin

James Henry Feusner
Email: protocols@swog.org

James Henry Feusner
Principal Investigator

Emeryville

Bay Area Breast Surgeons Inc

James Henry Feusner
Email: protocols@swog.org

James Henry Feusner
Principal Investigator

Epic Care Partners in Cancer Care

James Henry Feusner
Email: protocols@swog.org

James Henry Feusner
Principal Investigator

Fontana

Kaiser Permanente Hospital

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Fremont

Kaiser Permanente-Fremont

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Fresno

Kaiser Permanente

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

University Oncology Associates

Uzair Bashir Chaudhary
Ph: 559-447-4050

Uzair Bashir Chaudhary
Principal Investigator

Harbor City

Kaiser Permanente - Harbor City

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Irvine

Kaiser Permanente-Irvine

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Loma Linda

Loma Linda University Medical Center

Chung-Tsen Hsueh
Ph: 909-558-3375

Chung-Tsen Hsueh
Principal Investigator

Los Angeles

Kaiser Permanente Los Angeles Medical Center

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Kaiser Permanente-Cadillac

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Los Angeles County-USC Medical Center

Syma Iqbal
Ph: 323-865-0451

Syma Iqbal
Principal Investigator

USC / Norris Comprehensive Cancer Center

Syma Iqbal
Ph: 323-865-0451

Syma Iqbal
Principal Investigator

Martinez

Contra Costa Regional Medical Center

James Henry Feusner
Email: protocols@swog.org

James Henry Feusner
Principal Investigator

Modesto

Kaiser Permanente-Modesto

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Memorial Medical Center

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Mountain View

Palo Alto Medical Foundation-Camino Division

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Palo Alto Medical Foundation-Gynecologic Oncology

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Novato

Sutter Cancer Research Consortium

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Oakland

Alta Bates Summit Medical Center - Summit Campus

James Henry Feusner
Email: protocols@swog.org

James Henry Feusner
Principal Investigator

Bay Area Tumor Institute

James Henry Feusner
Email: protocols@swog.org

James Henry Feusner
Principal Investigator

Kaiser Permanente-Oakland

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Ontario

Kaiser Permanente-Ontario

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Orange

Saint Joseph Hospital - Orange

Anita K. Gregory
Ph: 714-734-6220

Anita K. Gregory
Principal Investigator

UC Irvine Health/Chao Family Comprehensive Cancer Center

Jason Adam Zell
Ph: 877-827-8839
Email: ucstudy@uci.edu

Jason Adam Zell
Principal Investigator

Palo Alto

Palo Alto Medical Foundation Health Care

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Panorama City

Kaiser Permanente - Panorama City

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Rancho Mirage

Eisenhower Medical Center

Luke Philip Dreisbach
Ph: 800-826-4673
Email: becomingapatient@coh.org

Luke Philip Dreisbach
Principal Investigator

Redwood City

Kaiser Permanente-Redwood City

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Richmond

Kaiser Permanente-Richmond

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Riverside

Kaiser Permanente-Riverside

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Roseville

Kaiser Permanente-Roseville

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Roseville

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Sutter Roseville Medical Center

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Sacramento

Kaiser Permanente - Sacramento

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Kaiser Permanente-South Sacramento

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Medical Center Sacramento

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

San Diego

Kaiser Permanente-San Diego Mission

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Kaiser Permanente-San Diego Zion

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

San Francisco

California Pacific Medical Center-Pacific Campus

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Kaiser Permanente-San Francisco

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

San Jose

Kaiser Permanente-Santa Teresa-San Jose

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

San Leandro

Kaiser Permanente San Leandro

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

San Marcos

Kaiser Permanente-San Marcos

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

San Rafael

Kaiser Permanente-San Rafael

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Santa Clara

Kaiser Permanente Medical Center - Santa Clara

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Santa Cruz

Palo Alto Medical Foundation-Santa Cruz

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Santa Rosa

Kaiser Permanente-Santa Rosa

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Pacific Medical Foundation

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

South San Francisco

Kaiser Permanente-South San Francisco

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Stockton

Kaiser Permanente-Stockton

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sunnyvale

Palo Alto Medical Foundation-Sunnyvale

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Vacaville

Kaiser Permanente Medical Center-Vacaville

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Vacaville

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Vallejo

Kaiser Permanente-Vallejo

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Solano Medical Center/Cancer Center

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Walnut Creek

Kaiser Permanente-Walnut Creek

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Woodland Hills

Kaiser Permanente

Han A. Koh
Ph: 626-564-3455

Han A. Koh
Principal Investigator

Colorado
Aurora

Rocky Mountain Cancer Centers-Aurora

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

University of Colorado Cancer Center - Anschutz Cancer Pavilion

Martin D. McCarter
Ph: 720-848-0650

Martin D. McCarter
Principal Investigator

Boulder

Boulder Community Hospital

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Boulder

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Colorado Springs

Memorial Hospital Central

Martin D. McCarter
Ph: 720-848-0650

Martin D. McCarter
Principal Investigator

Penrose-Saint Francis Healthcare

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Penrose

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Denver

Colorado Blood Cancer Institute

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Colorado Cancer Research Program NCORP

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Porter Adventist Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Presbyterian - Saint Lukes Medical Center - Health One

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Midtown

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Rose

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rose Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

SCL Health Saint Joseph Hospital

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Durango

Mercy Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Southwest Oncology PC

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Englewood

Comprehensive Cancer Care and Research Institute of Colorado LLC

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Swedish Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Fort Collins

Poudre Valley Hospital

Steven Robert Schuster
Ph: 855-776-0015

Steven Robert Schuster
Principal Investigator

Golden

Mountain Blue Cancer Care Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Greeley

North Colorado Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Greenwood Village

Rocky Mountain Cancer Centers-Greenwood Village

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Lakewood

Rocky Mountain Cancer Centers-Lakewood

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Saint Anthony Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Littleton

Littleton Adventist Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Littleton

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Lone Tree

Rocky Mountain Cancer Centers-Sky Ridge

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Longmont

Longmont United Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Longmont

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Loveland

McKee Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Parker

Parker Adventist Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Parker

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Pueblo

Rocky Mountain Cancer Centers - Pueblo

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Saint Mary Corwin Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Thornton

Rocky Mountain Cancer Centers-Thornton

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Wheat Ridge

SCL Health Lutheran Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Connecticut
Derby

Smilow Cancer Hospital-Derby Care Center

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

Greenwich

Greenwich Hospital

Beverly Joyce Drucker
Ph: 203-863-3698

Beverly Joyce Drucker
Principal Investigator

Guilford

Medical Oncology and Hematology Group PC-Guilford

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

Hartford

Smilow Cancer Hospital Care Center at Saint Francis

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

Middletown

Middlesex Hospital

Susanna Hong
Ph: 860-358-2058
Email: beth_slifer@midhosp.org

Susanna Hong
Principal Investigator

New Haven

Smilow Cancer Center/Yale-New Haven Hospital

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

Yale University

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

Orange

Smilow Cancer Hospital-Orange Care Center

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

Stamford

Stamford Hospital/Bennett Cancer Center

Salvatore A. Del Prete
Ph: 203-323-8944

Salvatore A. Del Prete
Principal Investigator

Torrington

Charlotte Hungerford Hospital Center for Cancer Care

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

Waterbury

Smilow Cancer Hospital-Waterbury Care Center

Sajid A. Khan
Ph: 203-785-5702

Sajid A. Khan
Principal Investigator

West Haven

Veterans Affairs Connecticut Healthcare System-West Haven Campus

Michal G. Rose
Ph: 203-937-3421ext2832

Michal G. Rose
Principal Investigator

Delaware
Lewes

Beebe Medical Center

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Newark

Christiana Care Health System-Christiana Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Delaware Clinical and Laboratory Physicians PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Helen F Graham Cancer Center

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Medical Oncology Hematology Consultants PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Regional Hematology and Oncology PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Rehoboth Beach

Beebe Health Campus

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Seaford

Nanticoke Memorial Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Wilmington

Christiana Care Health System-Wilmington Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

District of Columbia
Washington

Kaiser Permanente-Capitol Hill Medical Center

Leon Christopher Hwang
Ph: 301-548-5743

Leon Christopher Hwang
Principal Investigator

MedStar Georgetown University Hospital

John Lindsay Marshall
Ph: 202-444-2223

John Lindsay Marshall
Principal Investigator

MedStar Washington Hospital Center

John Lindsay Marshall
Ph: 202-444-2223

John Lindsay Marshall
Principal Investigator

Georgia
Albany

Phoebe Putney Memorial Hospital

Chirag R. Jani
Ph: 229-312-2251

Chirag R. Jani
Principal Investigator

Fort Gordon

Eisenhower Army Medical Center

Andrew S. Delmas
Ph: 706-787-2100

Andrew S. Delmas
Principal Investigator

Savannah

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

Howard A. Zaren
Ph: 912-819-5704

Howard A. Zaren
Principal Investigator

Hawaii
Aiea

Pali Momi Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Honolulu

Hawaii Cancer Care Inc-Liliha

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Hawaii Cancer Care Inc-POB II

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Hawaii Oncology Inc-Kuakini

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Kapiolani Medical Center for Women and Children

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Queen's Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Straub Clinic and Hospital

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

The Cancer Center of Hawaii-Liliha

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Tripler Army Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

University of Hawaii Cancer Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Lihue

Wilcox Memorial Hospital and Kauai Medical Clinic

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Idaho
Boise

Saint Alphonsus Cancer Care Center-Boise

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Luke's Mountain States Tumor Institute

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Caldwell

Saint Alphonsus Cancer Care Center-Caldwell

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Coeur D'Alene

Kootenai Medical Center

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Emmett

Walter Knox Memorial Hospital

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Fruitland

Saint Luke's Mountain States Tumor Institute - Fruitland

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Meridian

Idaho Urologic Institute-Meridian

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Luke's Mountain States Tumor Institute - Meridian

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Nampa

Saint Alphonsus Medical Center-Nampa

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Luke's Mountain States Tumor Institute - Nampa

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Post Falls

Kootenai Cancer Center

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Sandpoint

Kootenai Cancer Clinic

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Twin Falls

Saint Luke's Mountain States Tumor Institute-Twin Falls

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Illinois
Berwyn

Mac Neal Hospital

Irene Q. Ma
Ph: 708-783-0966

Irene Q. Ma
Principal Investigator

Bloomington

Illinois CancerCare-Bloomington

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Canton

Illinois CancerCare-Canton

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Carbondale

Memorial Hospital of Carbondale

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Carterville

SIH Cancer Institute

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Carthage

Illinois CancerCare-Carthage

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Centralia

Centralia Oncology Clinic

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Chicago

Presence Saint Joseph Hospital-Chicago

Ira Anton Oliff
Ph: 847-316-6994

Ira Anton Oliff
Principal Investigator

Weiss Memorial Hospital

Stuart A. Krauss
Ph: 773-564-5032

Stuart A. Krauss
Principal Investigator

Decatur

Decatur Memorial Hospital

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Effingham

Crossroads Cancer Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Eureka

Illinois CancerCare-Eureka

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Galesburg

Illinois CancerCare-Galesburg

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Western Illinois Cancer Treatment Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Harvey

Ingalls Memorial Hospital

Mark Farrell Kozloff
Ph: 773-834-7424

Mark Farrell Kozloff
Principal Investigator

Hines

Hines Veterans Administration Hospital

Abdul M. Choudhury
Ph: 708-202-8387

Abdul M. Choudhury
Principal Investigator

Kewanee

Illinois CancerCare-Kewanee Clinic

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Macomb

Illinois CancerCare-Macomb

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Ottawa

Illinois CancerCare-Ottawa Clinic

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Pekin

Illinois CancerCare-Pekin

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Peoria

Illinois CancerCare-Peoria

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Methodist Medical Center of Illinois

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

OSF Saint Francis Medical Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

OSF Saint Francis Radiation Oncology at Peoria Cancer Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Peru

Illinois CancerCare-Peru

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Princeton

Illinois CancerCare-Princeton

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

River Forest

West Suburban Medical Center

Isoken Koko
Ph: 708-783-0966

Isoken Koko
Principal Investigator

Rockford

OSF Saint Anthony Medical Center

Shylendra B. Sreenivasappa
Ph: 815-227-2633

Shylendra B. Sreenivasappa
Principal Investigator

Springfield

Memorial Medical Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Southern Illinois University School of Medicine

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Springfield Clinic

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Swansea

Cancer Care Specialists of Illinois-Swansea

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Memorial and Saint Elizabeth's Health Care Services LLP

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Indiana
Mishawaka

Memorial Regional Cancer Center Day Road

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Richmond

Reid Health

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

South Bend

Memorial Hospital of South Bend

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Northern Indiana Cancer Research Consortium

Robin T. Zon
Ph: 574-234-5123

Robin T. Zon
Principal Investigator

Iowa
Cedar Rapids

Physicians' Clinic of Iowa PC

William Patrick Fusselman
Ph: 319-297-2900
Email: cetscheidt@pcofiowa.com

William Patrick Fusselman
Principal Investigator

Clive

Medical Oncology and Hematology Associates-West Des Moines

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Mercy Cancer Center-West Lakes

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Council Bluffs

Alegent Health Mercy Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Creston

Greater Regional Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Des Moines

Iowa Lutheran Hospital

Robert J. Behrens
Ph: 515-239-2621

Robert J. Behrens
Principal Investigator

Iowa Methodist Medical Center

Robert J. Behrens
Ph: 515-239-2621

Robert J. Behrens
Principal Investigator

Iowa-Wide Oncology Research Coalition NCORP

Robert J. Behrens
Ph: 515-282-2921

Robert J. Behrens
Principal Investigator

Medical Oncology and Hematology Associates-Des Moines

Robert J. Behrens
Ph: 515-239-2621

Robert J. Behrens
Principal Investigator

Medical Oncology and Hematology Associates-Laurel

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Mercy Medical Center - Des Moines

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Mason City

Mercy Medical Center - North Iowa

Joginder (Joe) Singh
Ph: 800-433-3883

Joginder (Joe) Singh
Principal Investigator

Sioux City

Siouxland Regional Cancer Center

Donald B. Wender
Ph: 712-252-0088

Donald B. Wender
Principal Investigator

West Des Moines

Mercy Medical Center-West Lakes

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Methodist West Hospital

Robert J. Behrens
Ph: 515-239-2621

Robert J. Behrens
Principal Investigator

Kansas
Chanute

Cancer Center of Kansas - Chanute

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Dodge City

Cancer Center of Kansas - Dodge City

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

El Dorado

Cancer Center of Kansas - El Dorado

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Fort Scott

Cancer Center of Kansas - Fort Scott

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Garden City

Saint Catherine Hospital

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Hays

Hays Medical Center

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Independence

Cancer Center of Kansas-Independence

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Kansas City

University of Kansas Cancer Center

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

University of Kansas Cancer Center-West

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Kingman

Cancer Center of Kansas-Kingman

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Lawrence

Lawrence Memorial Hospital

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Liberal

Cancer Center of Kansas-Liberal

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Manhattan

Cancer Center of Kansas-Manhattan

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

McPherson

Cancer Center of Kansas - McPherson

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Newton

Cancer Center of Kansas - Newton

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Olathe

Olathe Medical Center

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Overland Park

University of Kansas Cancer Center-Overland Park

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Parsons

Cancer Center of Kansas - Parsons

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Pittsburg

Via Christi Hospital-Pittsburg

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Pratt

Cancer Center of Kansas - Pratt

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Salina

Cancer Center of Kansas - Salina

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Salina Regional Health Center

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Topeka

Saint Francis Hospital and Medical Center - Topeka

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Wellington

Cancer Center of Kansas - Wellington

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Wichita

Associates In Womens Health

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas - Wichita

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas-Wichita Medical Arts Tower

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Via Christi Regional Medical Center

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Wichita NCI Community Oncology Research Program

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Winfield

Cancer Center of Kansas - Winfield

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Kentucky
Bardstown

Flaget Memorial Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Corbin

Commonwealth Cancer Center-Corbin

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Lexington

Saint Joseph Hospital East

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Saint Joseph Radiation Oncology Resource Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Louisville

Jewish Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Jewish Hospital Medical Center Northeast

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Saints Mary and Elizabeth Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Shepherdsville

Jewish Hospital Medical Center South

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Louisiana
Baton Rouge

Louisiana Hematology Oncology Associates LLC

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

LSU Health Baton Rouge-North Clinic

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Medical Oncology LLC

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Ochsner Health Center-Summa

Burke Jay Brooks
Ph: 225-761-5278

Burke Jay Brooks
Principal Investigator

Houma

Mary Bird Perkins Cancer Center/Terrebonne General Medical Center

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Kenner

Ochsner Medical Center Kenner

Burke Jay Brooks
Ph: 225-761-5278

Burke Jay Brooks
Principal Investigator

Metairie

East Jefferson General Hospital

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

New Orleans

Louisiana State University Health Science Center

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Ochsner Medical Center Jefferson

Burke Jay Brooks
Ph: 225-761-5278

Burke Jay Brooks
Principal Investigator

University Medical Center New Orleans

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Maryland
Baltimore

Kaiser Permanente-Woodlawn Medical Center

Leon Christopher Hwang
Ph: 301-548-5743

Leon Christopher Hwang
Principal Investigator

University of Maryland/Greenebaum Cancer Center

Yixing Jiang
Ph: 800-888-8823

Yixing Jiang
Principal Investigator

Bel Air

Upper Chesapeake Medical Center

Yixing Jiang
Ph: 800-888-8823

Yixing Jiang
Principal Investigator

Cumberland

Western Maryland Regional Medical Center

Blanche Harry Mavromatis
Ph: 240-964-1400

Blanche Harry Mavromatis
Principal Investigator

Gaithersburg

Kaiser Permanente-Gaithersburg Medical Center

Leon Christopher Hwang
Ph: 301-548-5743

Leon Christopher Hwang
Principal Investigator

Largo

Kaiser Permanente - Largo Medical Center

Leon Christopher Hwang
Ph: 301-548-5743

Leon Christopher Hwang
Principal Investigator

Olney

Montgomery General Hospital-Olney

John Lindsay Marshall
Ph: 202-444-2223

John Lindsay Marshall
Principal Investigator

Massachusetts
Jamaica Plain

Boston Veteran's Affairs Medical Center

Valia A. Boosalis
Email: protocols@swog.org

Valia A. Boosalis
Principal Investigator

Michigan
Ann Arbor

Saint Joseph Mercy Hospital

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Battle Creek

Bronson Battle Creek

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Brighton

IHA Hematology Oncology Consultants-Brighton

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Joseph Mercy Brighton

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Canton

IHA Hematology Oncology Consultants-Canton

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Joseph Mercy Canton Health Center

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Caro

Caro Cancer Center

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Chelsea

IHA Hematology Oncology Consultants-Chelsea

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Joseph Mercy Chelsea

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Clarkston

Hematology Oncology Consultants-Clarkston

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Newland Medical Associates-Clarkston

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Dearborn

Beaumont Hospital-Dearborn

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Detroit

Saint John Hospital and Medical Center

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

East China

Great Lakes Cancer Management Specialists-Doctors Park

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Escanaba

Green Bay Oncology - Escanaba

Matthew L. Ryan
Ph: 920-433-8889
Email: Christy.Gilchrist@hshs.org

Matthew L. Ryan
Principal Investigator

Flint

Genesee Cancer and Blood Disease Treatment Center

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Genesee Hematology Oncology PC

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Genesys Hurley Cancer Institute

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Hurley Medical Center

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Gorsse Pointe Woods

Lymphoma Clinic of Michigan

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Grand Rapids

Mercy Health Saint Mary's

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Spectrum Health at Butterworth Campus

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Grosse Pointe Woods

Great Lakes Cancer Management Specialists-Van Elslander Cancer Center

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Michigan Breast Specialists-Grosse Pointe Woods

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Jackson

Allegiance Health

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Kalamazoo

West Michigan Cancer Center

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Lansing

Sparrow Hospital

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Lapeer

McLaren Cancer Institute-Lapeer Region

Justin F. Klamerus
Ph: 800-248-6777

Justin F. Klamerus
Principal Investigator

Livonia

Hope Cancer Clinic

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Mary Mercy Hospital

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Macomb Township

Hematology Oncology Associates East PC

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Michigan Breast Specialists-Macomb Township

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Mount Clemens

McLaren Cancer Institute-Macomb

Justin F. Klamerus
Ph: 800-248-6777

Justin F. Klamerus
Principal Investigator

Muskegon

Mercy Health Mercy Campus

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Niles

Lakeland Community Hospital

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Pontiac

21st Century Oncology-Pontiac

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Hope Cancer Center

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Newland Medical Associates-Pontiac

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Joseph Mercy Oakland

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Reed City

Spectrum Health Reed City Hospital

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Rochester Hills

Great Lakes Cancer Management Specialists-Rochester Hills

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saginaw

Oncology Hematology Associates of Saginaw Valley PC

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Mary's of Michigan

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint Joseph

Lakeland Hospital

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Marie Yeager Cancer Center

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Sterling Heights

Bhadresh Nayak MD PC-Sterling Heights

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Tawas City

Saint Joseph Health System-Tawas City

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Traverse City

Munson Medical Center

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Warren

Great Lakes Cancer Management Specialists-Macomb Professional Building

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Macomb Hematology Oncology PC

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Michigan Breast Specialists-Warren

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Saint John Macomb-Oakland Hospital

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

West Branch

Saint Mary's Oncology/Hematology Associates of West Branch

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Wyoming

Metro Health Hospital

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Ypsilanti

Huron Gastroenterology PC

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

IHA Hematology Oncology Consultants-Ann Arbor

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Minnesota
Burnsville

Fairview Ridges Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Coon Rapids

Mercy Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Duluth

Essentia Health Cancer Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Essentia Health Saint Mary's Medical Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Miller-Dwan Hospital

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Edina

Fairview-Southdale Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Fergus Falls

Lake Region Healthcare Corporation-Cancer Care

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Fridley

Unity Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Maple Grove

Fairview Maple Grove Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Maplewood

Minnesota Oncology Hematology PA-Maplewood

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Saint John's Hospital - Healtheast

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Minneapolis

Abbott-Northwestern Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Health Partners Inc

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Hennepin County Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

New Ulm

New Ulm Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Robbinsdale

North Memorial Medical Health Center

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Saint Cloud

Coborn Cancer Center at Saint Cloud Hospital

Donald James Jurgens
Ph: 877-229-4907

Donald James Jurgens
Principal Investigator

Saint Cloud Hospital

Donald James Jurgens
Ph: 877-229-4907

Donald James Jurgens
Principal Investigator

Saint Louis Park

Metro Minnesota Community Oncology Research Consortium

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Patrick James Flynn
Principal Investigator

Park Nicollet Clinic - Saint Louis Park

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Saint Paul

Regions Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

United Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Shakopee

Saint Francis Regional Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Stillwater

Lakeview Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Waconia

Ridgeview Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Willmar

Rice Memorial Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Woodbury

Minnesota Oncology Hematology PA-Woodbury

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Wyoming

Fairview Lakes Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Mississippi
Oxford

Family Cancer Center-Oxford

Carroll Dean Scroggin
Ph: 870-936-7000

Carroll Dean Scroggin
Principal Investigator

Pascagoula

Singing River Hospital

James E. Clarkson
Ph: 228-809-5292

James E. Clarkson
Principal Investigator

Southhaven

Baptist Memorial Hospital-Desoto

Carroll Dean Scroggin
Ph: 870-936-7000

Carroll Dean Scroggin
Principal Investigator

Missouri
Bonne Terre

Parkland Health Center-Bonne Terre

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Cape Girardeau

Saint Francis Medical Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Southeast Cancer Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Jefferson City

Capital Region Medical Center-Goldschmidt Cancer Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Kansas City

Kansas City Veterans Affairs Medical Center

January E. Fields-Meehan
Email: protocols@swog.org

January E. Fields-Meehan
Principal Investigator

The University of Kansas Cancer Center-North

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

The University of Kansas Cancer Center-South

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Truman Medical Center

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Lee's Summit

The University of Kansas Cancer Center-Lee's Summit

Stephen K. Williamson
Ph: 913-945-7552
Email: ctnursenav@kumc.edu

Stephen K. Williamson
Principal Investigator

Rolla

Delbert Day Cancer Institute at PCRMC

Eric M. Knoche
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Eric M. Knoche
Principal Investigator

Saint Louis

Missouri Baptist Medical Center

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Veteran's Affairs Medical Center - Saint Louis

Eric M. Knoche
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Eric M. Knoche
Principal Investigator

Sainte Genevieve

Sainte Genevieve County Memorial Hospital

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Sullivan

Missouri Baptist Sullivan Hospital

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Sunset Hills

Missouri Baptist Outpatient Center-Sunset Hills

James Lloyd Wade
Ph: 309-243-3605

James Lloyd Wade
Principal Investigator

Montana
Anaconda

Community Hospital of Anaconda

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Billings

Billings Clinic Cancer Center

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Montana Cancer Consortium NCORP

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Bozeman

Bozeman Deaconess Hospital

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Great Falls

Benefis Healthcare- Sletten Cancer Institute

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Great Falls Clinic

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Helena

Saint Peter's Community Hospital

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Kalispell

Kalispell Regional Medical Center

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Missoula

Community Medical Hospital

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Nebraska
Grand Island

CHI Health Saint Francis

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Kearney

CHI Health Good Samaritan

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Heartland Hematology and Oncology

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Lincoln

Saint Elizabeth Regional Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Omaha

Alegent Health Bergan Mercy Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Alegent Health Immanuel Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Alegent Health Lakeside Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Creighton University Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Hemotology and Oncology Consultants PC

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Missouri Valley Cancer Consortium

Gamini S. Soori
Ph: 402-398-6060

Gamini S. Soori
Principal Investigator

Papillion

Midlands Community Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Nevada
Henderson

21st Century Oncology - Henderson

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Henderson

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Henderson

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Southeast Henderson

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Henderson

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Las Vegas

21st Century Oncology

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

21st Century Oncology - Fort Apache

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

21st Century Oncology - Vegas Tenaya

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Shadow

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Tenaya

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Cancer Therapy and Integrative Medicine

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Central Valley

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Northwest

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Summerlin

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-San Martin

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Tenaya

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Medical Center

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Nevada Cancer Research Foundation CCOP

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Nevada Cancer Specialists-Fort Apache

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Central

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Southeast

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

University Medical Center of Southern Nevada

John Allan Ellerton
Ph: 805-474-9143

John Allan Ellerton
Principal Investigator

New Jersey
Morristown

Morristown Medical Center

Angela Tatiana Alistar
Ph: 973-971-5900

Angela Tatiana Alistar
Principal Investigator

Pompton

Chilton Memorial Hospital

Angela Tatiana Alistar
Ph: 973-971-5900

Angela Tatiana Alistar
Principal Investigator

Summit

Overlook Hospital

Angela Tatiana Alistar
Ph: 973-971-5900

Angela Tatiana Alistar
Principal Investigator

Vineland

Inspira Medical Center Vineland

Shailja Roy
Ph: 856-641-7933

Shailja Roy
Principal Investigator

Woodbury

Inspira Medical Center Woodbury

Carl J. Minniti
Ph: 856-641-7933

Carl J. Minniti
Principal Investigator

New York
Glens Falls

Glens Falls Hospital

Eric A. Pillemer
Ph: 518-926-6700

Eric A. Pillemer
Principal Investigator

New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone

Deirdre J. Cohen
Ph: 212-263-4434
Email: prmc.coordinator@nyumc.org

Deirdre J. Cohen
Principal Investigator

Stony Brook

Stony Brook University Medical Center

Minsig Choi
Ph: 313-576-9363

Minsig Choi
Principal Investigator

North Carolina
Belmont

Gaston Hematology and Oncology Associates-Belmont

William J. Charles
Ph: 704-834-2932

William J. Charles
Principal Investigator

Charlotte

Novant Health Presbyterian Medical Center

Nasfat Shehadeh
Ph: 704-384-5369

Nasfat Shehadeh
Principal Investigator

Gastonia

CaroMont Regional Medical Center

William J. Charles
Ph: 704-834-2932

William J. Charles
Principal Investigator

Gaston Hematology and Oncology Associates

William J. Charles
Ph: 704-834-2932

William J. Charles
Principal Investigator

Hendersonville

Hendersonville Hematology and Oncology at Pardee

James Earl Radford
Ph: 828-696-4716

James Earl Radford
Principal Investigator

Margaret R Pardee Memorial Hospital

James Earl Radford
Ph: 828-696-1341

James Earl Radford
Principal Investigator

North Dakota
Grand Forks

Altru Cancer Center

Grant Richard Seeger
Ph: 855-776-0015

Grant Richard Seeger
Principal Investigator

Minot

Trinity Cancer Care Center

Stephen N.C. Makoni
Ph: 800-862-0005

Stephen N.C. Makoni
Principal Investigator

Ohio
Belpre

Strecker Cancer Center-Belpre

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Centerville

Dayton Physicians LLC-Miami Valley South

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Miami Valley Hospital South

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Chillicothe

Adena Regional Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Cincinnati

Bethesda North Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Good Samaritan Hospital - Cincinnati

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Oncology Hematology Care Inc-Kenwood

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

TriHealth Cancer Institute-Anderson

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

TriHealth Cancer Institute-Westside

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Columbus

Columbus Oncology and Hematology Associates Inc

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Doctors Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Grant Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Mount Carmel East Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Mount Carmel Health Center West

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Ohio State University Comprehensive Cancer Center

Hisham Hussan
Ph: 800-293-5066
Email: Jamesline@osumc.edu

Hisham Hussan
Principal Investigator

Riverside Methodist Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

The Mark H Zangmeister Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Dayton

Dayton Physicians LLC-Samaritan North

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Good Samaritan Hospital - Dayton

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Miami Valley Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Samaritan North Health Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Delaware

Delaware Health Center-Grady Cancer Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Delaware Radiation Oncology

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Grady Memorial Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Findlay

Armes Family Cancer Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Blanchard Valley Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Orion Cancer Care

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Franklin

Atrium Medical Center-Middletown Regional Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Dayton Physicians LLC-Atrium

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Greenville

Dayton Physicians LLC-Wayne

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Wayne Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Kettering

Greater Dayton Cancer Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Kettering Medical Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Lancaster

Fairfield Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Marietta

Marietta Memorial Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Marion

OneHealth Marion General Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Middletown

Dayton Physicians LLC-Signal Point

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Mount Vernon

Knox Community Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Newark

Licking Memorial Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Newark Radiation Oncology

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Portsmouth

Southern Ohio Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Sidney

Dayton Physicians LLC-Wilson

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Springfield

Springfield Regional Cancer Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Springfield Regional Medical Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Troy

Dayton Physicians LLC-Upper Valley

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Upper Valley Medical Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Westerville

Saint Ann's Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

WPAFB

Wright-Patterson Medical Center

Susannah Catherine Cooper
Ph: 937-775-1350
Email: som_dcop@wright.edu

Susannah Catherine Cooper
Principal Investigator

Zanesville

Genesis Healthcare System Cancer Care Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Oklahoma
Oklahoma City

University of Oklahoma Health Sciences Center

George B. Selby
Ph: 405-271-8777
Email: ou-clinical-trials@ouhsc.edu

George B. Selby
Principal Investigator

Oregon
Baker City

Saint Alphonsus Medical Center-Baker City

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Bend

Saint Charles Health System

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Clackamas

Clackamas Radiation Oncology Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Providence Oncology and Hematology Care Southeast

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Coos Bay

Bay Area Hospital

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Newberg

Providence Newberg Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Ontario

Saint Alphonsus Medical Center-Ontario

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Oregon City

Providence Willamette Falls Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Portland

Providence Portland Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Providence Saint Vincent Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Pennsylvania
Allentown

Lehigh Valley Hospital-Cedar Crest

Philip J. Stella
Ph: 208-367-7954

Philip J. Stella
Principal Investigator

Bryn Mawr

Bryn Mawr Hospital

Albert S. DeNittis
Ph: 484-476-2649
Email: ewend@mlhs.org

Albert S. DeNittis
Principal Investigator

Media

Riddle Memorial Hospital

Albert S. DeNittis
Ph: 484-476-2649
Email: ewend@mlhs.org

Albert S. DeNittis
Principal Investigator

Paoli

Paoli Memorial Hospital

Albert S. DeNittis
Ph: 484-476-2649
Email: ewend@mlhs.org

Albert S. DeNittis
Principal Investigator

Phoenixville

Phoenixville Hospital

Carl W. Sharer
Ph: 610-983-1908

Carl W. Sharer
Principal Investigator

Wynnewood

Lankenau Medical Center

Albert S. DeNittis
Ph: 484-476-2649
Email: ewend@mlhs.org

Albert S. DeNittis
Principal Investigator

South Carolina
Greenville

Greenville Health System Cancer Institute-Butternut

Jeffrey Kent Giguere
Ph: 864-679-3966

Jeffrey Kent Giguere
Principal Investigator

Greenville Health System Cancer Institute-Eastside

Jeffrey Kent Giguere
Ph: 864-679-3966

Jeffrey Kent Giguere
Principal Investigator

Greenville Health System Cancer Institute-Faris

Jeffrey Kent Giguere
Ph: 864-679-3966

Jeffrey Kent Giguere
Principal Investigator

Greenville Memorial Hospital

Jeffrey Kent Giguere
Ph: 864-679-3966

Jeffrey Kent Giguere
Principal Investigator

Greer

Greenville Health System Cancer Institute-Greer

Jeffrey Kent Giguere
Ph: 864-679-3966

Jeffrey Kent Giguere
Principal Investigator

Seneca

Greenville Health System Cancer Institute-Seneca

Jeffrey Kent Giguere
Ph: 864-679-3966

Jeffrey Kent Giguere
Principal Investigator

Spartanburg

Greenville Health System Cancer Institute-Spartanburg

Jeffrey Kent Giguere
Ph: 864-679-3966

Jeffrey Kent Giguere
Principal Investigator

Tennessee
Chattanooga

Memorial Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Collierville

Baptist Memorial Hospital-Collierville

Carroll Dean Scroggin
Ph: 870-936-7000

Carroll Dean Scroggin
Principal Investigator

Hixson

Pulmonary Medicine Center of Chattanooga-Hixson

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Knoxville

University of Tennessee - Knoxville

Wahid T. Hanna
Ph: 865-544-9773

Wahid T. Hanna
Principal Investigator

Memphis

Baptist Memorial Hospital and Cancer Center-Memphis

Carroll Dean Scroggin
Ph: 870-936-7000

Carroll Dean Scroggin
Principal Investigator

Ooltewah

Memorial GYN Plus

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Texas
Bryan

Saint Joseph Regional Cancer Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

San Antonio

University of Texas Health Science Center at San Antonio

Sukeshi Patel Arora
Ph: 210-450-3800
Email: CTO@uthscsa.edu

Sukeshi Patel Arora
Principal Investigator

Virginia
Burke

Kaiser Permanente-Burke Medical Center

Leon Christopher Hwang
Ph: 301-548-5743

Leon Christopher Hwang
Principal Investigator

Martinsville

Memorial Hospital Of Martinsville

Sreedhar Katragadda
Ph: 276-666-7827

Sreedhar Katragadda
Principal Investigator

McLean

Kaiser Permanente Tysons Corner Medical Center

Leon Christopher Hwang
Ph: 301-548-5743

Leon Christopher Hwang
Principal Investigator

Washington
Aberdeen

Providence Regional Cancer System-Aberdeen

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Auburn

MultiCare Auburn Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bainbridge Island

Virginia Mason Bainbridge Island Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bellevue

Overlake Hospital Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bellingham

PeaceHealth Saint Joseph Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Bremerton

Harrison HealthPartners Hematology and Oncology-Bremerton

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Harrison Medical Center

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Burien

Highline Medical Center-Main Campus

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Centralia

Providence Regional Cancer System-Centralia

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Edmonds

Swedish Medical Center-Edmonds

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Enumclaw

Saint Elizabeth Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Everett

Providence Regional Cancer Partnership

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Federal Way

Saint Francis Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Virginia Mason Federal Way Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Gig Harbor

MultiCare Gig Harbor Medical Park

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Gig Harbor

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Issaquah

Swedish Cancer Institute-Issaquah

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Kennewick

Northwest Cancer Clinic

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Lacey

Providence Regional Cancer System-Lacey

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Lakewood

Saint Clare Hospital

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Longview

PeaceHealth Saint John Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Lynnwood

Virginia Mason Lynnwood Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Port Townsend

Jefferson Healthcare

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Poulsbo

Harrison HealthPartners Hematology and Oncology-Poulsbo

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Peninsula Cancer Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Puyallup

MultiCare Good Samaritan Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Puyallup

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Renton

Valley Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Seattle

Group Health Cooperative-Seattle

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Pacific Gynecology Specialists

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Swedish Medical Center-Ballard Campus

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Swedish Medical Center-First Hill

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Virginia Mason Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Shelton

Providence Regional Cancer System-Shelton

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Spokane

Rockwood Cancer Treatment Center-DHEC-Downtown

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Spokane Valley

Rockwood Clinic Cancer Treatment Center-Valley

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Tacoma

Franciscan Research Center-Northwest Medical Plaza

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

MultiCare Tacoma General Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Northwest Medical Specialties PLLC

Mehmet Sitki Copur
Ph: 501-622-2100

Mehmet Sitki Copur
Principal Investigator

Northwest NCI Community Oncology Research Program

John A. Keech
Ph: 253-403-2394

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Jackson Hall

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Saint Joe's

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Vancouver

PeaceHealth Southwest Medical Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Walla Walla

Providence Saint Mary Regional Cancer Center

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

Yakima

North Star Lodge Cancer Center at Yakima Valley Memorial Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Yelm

Providence Regional Cancer System-Yelm

Gary E. Goodman
Ph: 907-212-6871
Email: AKPAMC.OncologyResearchSupport@providence.org

Gary E. Goodman
Principal Investigator

West Virginia
Huntington

Saint Mary's Medical Center

Arvinder Singh Bir
Ph: 888-823-5923
Email: ctsucontact@westat.com

Arvinder Singh Bir
Principal Investigator

Princeton

Princeton Community Hospital

David Arthur Mullins
Ph: 304-487-7000

David Arthur Mullins
Principal Investigator

Wisconsin
Antigo

Langlade Hospital and Cancer Center

Christopher Gary Peterson
Ph: 877-405-6866

Christopher Gary Peterson
Principal Investigator

Chippewa Falls

Marshfield Clinic-Chippewa Center

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Eau Claire

Marshfield Clinic Cancer Center at Sacred Heart

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Green Bay

Green Bay Oncology Limited at Saint Mary's Hospital

Matthew L. Ryan
Ph: 920-433-8889

Matthew L. Ryan
Principal Investigator

Saint Vincent Hospital Cancer Center at Saint Mary's

Matthew L. Ryan
Ph: 920-433-8889
Email: Christy.Gilchrist@hshs.org

Matthew L. Ryan
Principal Investigator

Saint Vincent Hospital Cancer Center Green Bay

Matthew L. Ryan
Ph: 920-433-8889
Email: Christy.Gilchrist@hshs.org

Matthew L. Ryan
Principal Investigator

Manitowoc

Holy Family Memorial Hospital

Matthew L. Ryan
Ph: 920-433-8889
Email: Christy.Gilchrist@hshs.org

Matthew L. Ryan
Principal Investigator

Marshfield

Marshfield Clinic

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Minocqua

Marshfield Clinic-Minocqua Center

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

New Richmond

Cancer Center of Western Wisconsin

Patrick James Flynn
Ph: 952-993-1517
Email: mmcorc@healthpartners.com

Patrick James Flynn
Principal Investigator

Oconto Falls

Green Bay Oncology - Oconto Falls

Matthew L. Ryan
Ph: 920-433-8889
Email: Christy.Gilchrist@hshs.org

Matthew L. Ryan
Principal Investigator

Rice Lake

Marshfield Clinic-Rice Lake Center

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Sheboygan

HSHS Saint Nicholas Hospital

Matthew L. Ryan
Ph: 920-433-8889
Email: Christy.Gilchrist@hshs.org

Matthew L. Ryan
Principal Investigator

Stevens Point

Marshfield Clinic Stevens Point Center

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Sturgeon Bay

Green Bay Oncology - Sturgeon Bay

Matthew L. Ryan
Ph: 920-433-8889

Matthew L. Ryan
Principal Investigator

Saint Vincent Hospital Cancer Center at Sturgeon Bay

Matthew L. Ryan
Ph: 920-433-8889
Email: Christy.Gilchrist@hshs.org

Matthew L. Ryan
Principal Investigator

Wausau

Aspirus Regional Cancer Center

Christopher Gary Peterson
Ph: 877-405-6866

Christopher Gary Peterson
Principal Investigator

Marshfield Clinic-Wausau Center

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Weston

Marshfield Clinic - Weston Center

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Wisconsin Rapids

Marshfield Clinic - Wisconsin Rapids Center

Muhammad Imran Moid
Ph: 800-847-0016

Muhammad Imran Moid
Principal Investigator

Wyoming
Cheyenne

Cheyenne Regional Medical Center-West

Keren Sturtz
Ph: 303-777-2663
Email: ccrp@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Cody

Billings Clinic-Cody

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Sheridan

Welch Cancer Center

Benjamin T. Marchello
Ph: 406-969-6060
Email: mccinfo@mtcancer.org

Benjamin T. Marchello
Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifier NCT01349881

Note: Information about participating sites on pharmaceutical industry trials may be incomplete. Please visit the ClinicalTrials.gov record via the link above for more information about participating sites.